Page last updated: 2024-09-03

bw a1433u and 5-hydroxydecanoate

bw a1433u has been researched along with 5-hydroxydecanoate in 1 studies

Compound Research Comparison

Studies (bw a1433u)	Trials (bw a1433u)	Recent Studies (post-2010) (bw a1433u)	Studies (5-hydroxydecanoate)	Trials (5-hydroxydecanoate)	Recent Studies (post-2010) (5-hydroxydecanoate)
26	0	0	431	0	93

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hill, RJ; Magee, W; Masamune, H; Oleynek, JJ; Tracey, WR	1

Other Studies

1 other study(ies) available for bw a1433u and 5-hydroxydecanoate

Article	Year
Selective activation of adenosine A3 receptors with N6-(3-chlorobenzyl)-5'-N-methylcarboxamidoadenosine (CB-MECA) provides cardioprotection via KATP channel activation. Cardiovascular research, 1998, Volume: 40, Issue:1 Topics: Adenosine; Adenylyl Cyclases; Animals; Anti-Arrhythmia Agents; Binding, Competitive; CHO Cells; Colforsin; Cricetinae; Cyclic AMP; Decanoic Acids; Dose-Response Relationship, Drug; Glyburide; Hydroxy Acids; Hypoglycemic Agents; Myocardial Reperfusion Injury; Myocardium; Perfusion; Potassium Channels; Rabbits; Receptor, Adenosine A3; Receptors, Purinergic P1; Xanthines	1998

Article

Year

Selective activation of adenosine A3 receptors with N6-(3-chlorobenzyl)-5'-N-methylcarboxamidoadenosine (CB-MECA) provides cardioprotection via KATP channel activation.

Cardiovascular research, 1998, Volume: 40, Issue:1

Topics: Adenosine; Adenylyl Cyclases; Animals; Anti-Arrhythmia Agents; Binding, Competitive; CHO Cells; Colforsin; Cricetinae; Cyclic AMP; Decanoic Acids; Dose-Response Relationship, Drug; Glyburide; Hydroxy Acids; Hypoglycemic Agents; Myocardial Reperfusion Injury; Myocardium; Perfusion; Potassium Channels; Rabbits; Receptor, Adenosine A3; Receptors, Purinergic P1; Xanthines

1998